Thrombophilia Package (Leiden mutation, mutation in the part II gene, C677T mutation in the MTHFR gene)

• The material for testing is blood.
• The patient does not need to fast. It is recommended to drink a glass of water approximately 30 minutes before the examination.

Samples brought from outside are not accepted for testing.

The most common symptom of congenital thrombophilia is deep vein thrombosis of the lower limbs. Thrombophilia is considered one of the main risk factors for venous thromboembolism. It is detected in 41% of patients with deep vein thrombosis. The risk of thrombosis is highest in patients with antithrombin deficiency.
Thrombotic changes due to congenital or acquired thrombophilia can cause recurrent miscarriages, intrauterine fetal death, premature placental abruption, and preeclampsia. Genetic testing for thrombophilia is currently recommended in cases of two or more miscarriages in a single partnership.
It is estimated that the factor V Leiden mutation is responsible for approximately 20% of obstetric complications, while the factor II mutation accounts for approximately 10% of cases. The risk of miscarriage increases with the additional presence of polymorphisms in the MTHFR gene. Women who have experienced recurrent miscarriages should be tested for Factor V Leiden, prothrombin gene mutations, and selected MTHFR mutations.
The thrombophilia package detects Factor V Leiden mutations, Factor II gene mutations, and the C677T mutation in the MTHFR gene.

Enter one-time code: Show
Invalid code entered. Please try again.